Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × Share of holding: 50% or more × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

2,347 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

2,347 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

2,347 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

2,347 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
2,347 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
2,347 decisions over 12 months Remove this filter
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

2,347 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
14 Nov 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 4×
$1.85M 4,000 at 462.94
96.9%
Sold half or more
14 Nov 2025
Brannan Andrew EVP, Worldwide Sales
Sold on a plan 3×
$1.06M 8,913 at 119.06
60.0%
Sold half or more
13 Nov 2025
Fernandez Jose A Co-Chief Operating Officer · indirect
Sold on a plan 2×
$4.39M 70,402 at 62.30
100%
Sold half or more
13 Nov 2025
Randhawa Simrat EVP, Head of R&D
Sold on a plan 3×
$3.22M 87,507 at 36.81
95.6%
Sold half or more
13 Nov 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 4×
$2.92M 4,000 at 728.96
96.9%
Sold half or more
13 Nov 2025
Sold on a plan 2×
$939.49K 40,504 at 23.20
64.7%
Sold half or more
13 Nov 2025
Jamil Khurram Chief Medical Officer
Sold on a plan 4×
$662.51K 121,117 at 5.47
96.4%
Sold half or more
13 Nov 2025
BENDHEIM JACK President and CEO · indirect
Sold on a plan 2×
$391.42K 8,801 at 44.47
62.7%
Sold half or more
13 Nov 2025
Rawcliffe Adrian Director
Sold on a plan
$109.42K 16,115 at 6.79
55.9%
Sold half or more
12 Nov 2025
Venturo Brian M Chief Strategy Officer · indirect
Sold on a plan 8×
$24.63M 281,250 at 87.57
100%
Sold half or more
12 Nov 2025
Charlton Henry L EVP & Chief Commercial and Mkt
Sold on a plan 5×
$7.96M 13,731 at 580.00
81.8%
Sold half or more
12 Nov 2025
Telman Deborah H EVP, Corporate Affairs & GC
Sold on a plan 3×
$6.59M 53,646 at 122.85
55.1%
Sold half or more
12 Nov 2025
Fernandez Jose A Co-Chief Operating Officer · indirect
Sold on a plan 3×
$4.41M 70,404 at 62.65
50.0%
Sold half or more
12 Nov 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 6×
$1.84M 4,000 at 460.00
96.9%
Sold half or more
12 Nov 2025
Kuzoyan Vahe President
Sold on a plan 3×
$1.52M 16,388 at 92.52
100.0%
Sold half or more
12 Nov 2025
BENDHEIM JACK President and CEO · indirect
Sold on a plan
$973.98K 21,536 at 45.23
60.5%
Sold half or more
12 Nov 2025
Reeve Emma Director
Sold on a plan
$546.31K 7,333 at 74.50
52.4%
Sold half or more
12 Nov 2025
BARRATT CRAIG H Director
Sold on a plan
$435.00K 750 at 580.00
100%
Sold half or more
12 Nov 2025
Lee Chan Henry SVP, General Counsel
Sold on a plan 2×
$347.77K 996 at 349.17
100%
Sold half or more
12 Nov 2025
D'Amico Andrew Director
Sold on a plan 3×
$189.15K 1,908 at 99.13
100%
Sold half or more
11 Nov 2025
Baszucki David President & CEO · indirect
Sold on a plan 4×
$6.99M 66,896 at 104.53
100%
Sold half or more
11 Nov 2025
Kaiser Jason Group President
Sold on a plan 13×
$6.03M 10,707 at 563.60
55.3%
Sold half or more
11 Nov 2025
Skates Spenser Chief Executive Officer · indirect
Sold on a plan
$4.40M 400,000 at 10.99
100%
Sold half or more
11 Nov 2025
Bialecki Andrew Chief Executive Officer
Sold on a plan
$4.18M 140,464 at 29.74
100%
Sold half or more
11 Nov 2025
Farkas K Christopher Vice President and CFO
Sold on a plan
$2.92M 5,047 at 577.91
54.4%
Sold half or more
11 Nov 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 3×
$1.81M 4,000 at 451.82
96.9%
Sold half or more
11 Nov 2025
DUNN JEFFREY W Director
Sold on a plan 2×
$1.52M 80,000 at 18.95
88.6%
Sold half or more
11 Nov 2025
Kuzoyan Vahe President
Sold on a plan 4×
$1.51M 16,388 at 92.03
100.0%
Sold half or more
11 Nov 2025
Spiegel Reuven EVP, Special Projects
Sold on a plan 2×
$1.12M 27,000 at 41.36
54.0%
Sold half or more
11 Nov 2025
Oelschlager Kristen M Chief Operating Officer
Sold on a plan
$664.51K 18,932 at 35.10
60.6%
Sold half or more
11 Nov 2025
Aurora Daljit Singh See Remarks · indirect
Sold on a plan
$307.03K 114,703 at 2.68
100%
Sold half or more
11 Nov 2025
Lee James CI EVP & CLO
Sold on a plan
$201.42K 697 at 288.98
73.1%
Sold half or more
11 Nov 2025
Sold on a plan
$86.25K 3,591 at 24.02
97.3%
Sold half or more
11 Nov 2025
Ribeiro Ramiro Chief Medical Officer
Sold on a plan
$31.60K 2,722 at 11.61
100%
Sold half or more
10 Nov 2025
Gebbia Joseph Director · indirect
Sold on a plan 4×
$28.47M 236,000 at 120.66
50.4%
Sold half or more
10 Nov 2025
Ehrsam Frederick Ernest III Director · indirect
Sold on a plan 5×
$17.92M 55,688 at 321.81
100%
Sold half or more
10 Nov 2025
BENKOWITZ MICHAEL PRESIDENT AND COO · indirect
Sold on a plan 2×
$10.17M 22,500 at 452.07
100%
Sold half or more
10 Nov 2025
EDGEMOND JAMES CFO AND TREASURER
Sold on a plan 10×
$9.49M 21,000 at 452.07
72.1%
Sold half or more
10 Nov 2025
Armstrong Brian Chairman and CEO · indirect
Sold on a plan 6×
$8.02M 25,000 at 320.67
97.9%
Sold half or more
10 Nov 2025
Wood Anthony J. CEO and Chairman BOD · indirect
Sold on a plan 6×
$5.19M 50,000 at 103.86
100%
Sold half or more
10 Nov 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 2×
$1.79M 4,000 at 448.39
96.9%
Sold half or more
10 Nov 2025
BENDHEIM JACK President and CEO · indirect
Sold on a plan 4×
$1.73M 38,303 at 45.29
65.1%
Sold half or more
10 Nov 2025
Sold on a plan
$461.64K 19,227 at 24.01
99.5%
Sold half or more
10 Nov 2025
Curet Myriam EVP & Chief Medical Officer
Sold on a plan
$58.80K 105 at 560.00
100%
Sold half or more
10 Nov 2025
Moreadith Randall Chief Scientific Officer
Sold on a plan
$26.65K 6,500 at 4.10
100%
Sold half or more
7 Nov 2025
Speiser Michael L Director · indirect
Sold on a plan 12×
$12.95M 50,338 at 257.30
60.0%
Sold half or more
7 Nov 2025
Ehrsam Frederick Ernest III Director · indirect
Sold on a plan 7×
$5.75M 19,927 at 288.77
100%
Sold half or more
7 Nov 2025
ROTHBLATT MARTINE A Chairperson & CEO
Sold on a plan 3×
$1.79M 4,000 at 448.25
96.9%
Sold half or more
7 Nov 2025
Rutledge Napoleon B JR SVP, Controller & CAO
Sold on a plan
$283.48K 329 at 861.63
50.1%
Sold half or more
7 Nov 2025
Grech Patricia Y SVP & CAO · indirect
Sold on a plan
$35.09K 203 at 172.87
100%
Sold half or more
Showing 2,201–2,250 of 2,347. ← Newer Page 45 of 47 Older →